Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Serum selenoprotein P, but not selenium, predicts future hyperglycemia in a general Japanese population.

Oo SM, Misu H, Saito Y, Tanaka M, Kato S, Kita Y, Takayama H, Takeshita Y, Kanamori T, Nagano T, Nakagen M, Urabe T, Matsuyama N, Kaneko S, Takamura T.

Sci Rep. 2018 Nov 13;8(1):16727. doi: 10.1038/s41598-018-35067-2.

2.

Fasting tests of insulin secretion and sensitivity predict future prediabetes in Japanese with normal glucose tolerance.

Onishi Y, Hayashi T, Sato KK, Ogihara T, Kuzuya N, Anai M, Tsukuda K, Boyko EJ, Fujimoto WY, Kikuchi M.

J Diabetes Investig. 2010 Oct 19;1(5):191-5. doi: 10.1111/j.2040-1124.2010.00041.x.

3.

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.

Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T; Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus.

Diabetes Res Clin Pract. 2002 Jan;55(1):65-85.

PMID:
11755481
4.

Circulating Concentrations of Insulin Resistance-Associated Hepatokines, Selenoprotein P and Leukocyte Cell-Derived Chemotaxin 2, during an Oral Glucose Tolerance Test in Humans.

Mohri K, Misu H, Takayama H, Ishii KA, Kikuchi A, Lan F, Enyama Y, Takeshita Y, Saito Y, Kaneko S, Takamura T.

Biol Pharm Bull. 2019 Mar 1;42(3):373-378. doi: 10.1248/bpb.b18-00549. Epub 2018 Dec 28.

5.

Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.

Utzschneider KM, Prigeon RL, Faulenbach MV, Tong J, Carr DB, Boyko EJ, Leonetti DL, McNeely MJ, Fujimoto WY, Kahn SE.

Diabetes Care. 2009 Feb;32(2):335-41. doi: 10.2337/dc08-1478. Epub 2008 Oct 28. Erratum in: Diabetes Care. 2009 Jul;32(7):1355.

6.

Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study.

Kayaniyil S, Retnakaran R, Harris SB, Vieth R, Knight JA, Gerstein HC, Perkins BA, Zinman B, Hanley AJ.

Diabetes. 2011 Nov;60(11):2947-53. doi: 10.2337/db11-0465. Epub 2011 Sep 12.

7.

K-value and low insulin secretion in a non-obese white population: predicted glucose tolerance after 25 years.

Alvarsson M, Wajngot A, Cerasi E, Efendic S.

Diabetologia. 2005 Nov;48(11):2262-8. Epub 2005 Sep 14.

PMID:
16160865
8.

Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese.

Oka R, Yagi K, Sakurai M, Nakamura K, Moriuchi T, Miyamoto S, Nohara A, Kawashiri MA, Takeda Y, Yamagishi M.

Endocr J. 2012;59(1):55-64. Epub 2011 Nov 9.

9.

Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.

Ozeki N, Hara K, Yatsuka C, Nakano T, Matsumoto S, Suetsugu M, Nakamachi T, Takebayashi K, Inukai T, Haruki K, Aso Y.

Metabolism. 2009 Oct;58(10):1470-6. doi: 10.1016/j.metabol.2009.04.042. Epub 2009 Jul 9.

PMID:
19592051
10.

The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes.

Aso Y, Terasawa T, Kato K, Jojima T, Suzuki K, Iijima T, Kawagoe Y, Mikami S, Kubota Y, Inukai T, Kasai K.

Transl Res. 2013 Nov;162(5):309-16. doi: 10.1016/j.trsl.2013.07.011. Epub 2013 Aug 30.

PMID:
23994650
12.

[Role of insulin resistance and β cell function in the development of newly diagnosed type 2 diabetes].

Chen X, Su M, Wang C, Wu Z, Li S, Ying X, Wei G, Fu C, Jiang Q.

Wei Sheng Yan Jiu. 2015 Nov;44(6):881-6. Chinese.

PMID:
26738376
13.
14.
15.

Retinol-binding protein 4 (RBP-4) levels do not change after oral glucose tolerance test and after dexamethasone, but correlate with some indices of insulin resistance in humans.

Lewandowski KC, Basinska-Lewandowska M, Bieńkiewicz M, Randeva HS, Lewiński A.

Endokrynol Pol. 2008 Jul-Aug;59(4):305-11.

PMID:
18777500
16.

Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study.

Surdacki A, Kruszelnicka O, Rakowski T, Jaźwińska-Kozuba A, Dubiel JS.

Cardiovasc Diabetol. 2013;12:64. doi: 10.1186/1475-2840-12-64.

17.

Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.

Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y.

Diabetes Care. 1997 Oct;20(10):1562-8.

PMID:
9314636
18.

Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia.

Suzuki H, Fukushima M, Usami M, Ikeda M, Taniguchi A, Nakai Y, Matsuura T, Kuroe A, Yasuda K, Kurose T, Seino Y, Yamada Y.

Diabetes Care. 2003 Apr;26(4):1211-5.

PMID:
12663599
19.

Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.

Viswanathan V, Clementina M, Nair BM, Satyavani K.

J Assoc Physicians India. 2007 Dec;55:833-7.

PMID:
18405128
20.

Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study.

Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M; Bruneck study.

Diabetes. 2004 Jul;53(7):1782-9.

Supplemental Content

Support Center